Safety Profile of Baricitinib For the Treatment of Rheumatoid Arthritis Over a Median of 3 Years of Treatment: An Updated Integrated Safety Analysis
Lancet Rheumatol 2020;2:e347–57
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Lancet Rheumatol 2020;2:e347–57
Clin Exp Rheumatol . Jul-Aug 2020;38(4):732-741. Epub 2020 May 20.
Arthritis Rheumatol. 2020 Sep; 72(9): 1435–1446.
RMD Open 2020;6:e001095
Drug Saf. 2020;43:379-392
Z Rheumatol. 2020 DOI: 10.1007/s00393-020-00750-1
Intern Med. 2020;59(6):817-821
Ther Adv Musculoskelet Dis. 2020;12:1759720X19899296
Clin Transl Sci . 2020 Mar;13(2):325-336. doi: 10.1111/cts.12713. Epub 2019 Nov 29.
Please click the links below to go to the CSF review of each paper